06.11.2018 14:45:09
|
ANI Pharmaceuticals, Inc. Q3 adjusted earnings Beat Estimates
(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced a profit for its third quarter that climbed from the same period last year.
The company's profit totaled $5.04 million, or $0.42 per share. This compares with $4.72 million, or $0.40 per share, in last year's third quarter.
Analysts had expected the company to earn $1.17 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 5.3% to $50.70 million from $48.16 million last year.
ANI Pharmaceuticals, Inc. earnings at a glance:
-Earnings (Q3): . vs. . last year. -EPS (Q3): $1.29 vs. $1.11 last year. -Analysts Estimate: $1.17 -Revenue (Q3): $50.70 Mln vs. $48.16 Mln last year.
-Guidance: Full year EPS guidance: $4.80 to $5.27 Full year revenue guidance: $195 to $205 Million
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biosante Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |